Clinical Trial Update: Phase I Study to Assess the Effect on Healthy Male Volunteers of Ketoconazole on the Pharmacokinetics of a Single Dose of AZD5069 Administered Orally. [Phase 1]

View source ↗

Summary

Phase I study in healthy male volunteers to evaluate the effect of ketoconazole on the pharmacokinetics of a single oral dose of AZD5069, including PK parameter…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• AZD5069 (CXCR2 inhibitor)
• Ketoconazole (Ketoconazole)

Snippet

Sponsor: AstraZeneca | Conditions: Asthma,, Pharmacokinetics, | Phase 1 | Status: COMPLETED